Buzz builds for honey treatments
Researchers are racing against the clock to find a viable alternative to traditional antibiotics, as bacteria continues to build resistance against new drugs at a frightening rate.
Researchers are racing against the clock to find a viable alternative to traditional antibiotics, as bacteria continues to build resistance against new drugs at a frightening rate.
Biochemistry
Mar 21, 2013
0
0
In 2010 malaria caused an estimated 665,000 deaths, mostly among African children. Now, chemists at Indiana University have developed a new synthesis for the world's most useful antimalarial drug, artemisinin, giving hope ...
Biochemistry
Sep 13, 2012
0
0
Researchers from the University of Kentucky have designed and discovered a series of highly efficient enzymes that effectively metabolize cocaine. These high-activity cocaine-metabolizing enzymes could potentially prevent ...
Other
Jul 26, 2012
0
0
Cancer is one of the five leading causes of death. And yet, despite decades of research, there is no standardized first-line treatment for most cancers. In addition, disappointing results from predominant second-line treatments ...
Mathematics
Jan 25, 2012
0
0
Measured in billionths of a meter, self-assembling nano-sized devices designed to carry drugs and imaging agents into the body are revolutionizing medicine by improving drug solubility and bio-distribution, providing a platform ...
Bio & Medicine
Jun 7, 2011
0
0
Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as ...
Biochemistry
May 12, 2011
0
0
Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.
Other
Jul 14, 2010
0
0
(PhysOrg.com) -- A protein that plays a key role in copying DNA also plays a vital role in repairing breaks in it, UC Davis scientists have found. The work is helping researchers understand how cancer cells can resist radiation ...
Cell & Microbiology
Dec 3, 2009
0
0
Since the revelation of poly(ADP-ribose) polymerase (PARP) inhibitors and their remarkable results in the treatment of BRCA1/2 mutant cancers, synthetic lethality (SL) in antitumor therapy has attracted increasing attention. ...
Bio & Medicine
Mar 14, 2024
0
17
A joint research paper from Chemnitz University of Technology and Shivaji University (India) titled "APTES monolayer coverage on self-assembled magnetic nanospheres for controlled release of anticancer drug Nintedanib" was ...
Bio & Medicine
Apr 27, 2022
0
20